Project funding
Ended Definitive Contract Awarded Last action
- Contract number
- HDTRA106C0042
- Awardee
-
Microbiotix, Inc. UEI SCNKBDM341T1
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Obligated
- $5,050,492
Award facts
- Contract value 100% obligated
- $5,057,523.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Threat Reduction Agency Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 113 offers Negotiated Proposal / Quote
- Pricing
- Combination (two or more)
- Place of performance
- Worcester, MA 01605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,031 | |
| Other Administrative Action | -$7,031 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $2,007,344 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $669,115 | |
| Original award | $2,388,096 |
About this award
This is a $5,057,523.60 definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Microbiotix, Inc., a clinical-stage biopharmaceutical company. The contract, which is not set-aside, supports the development of novel small molecule anti-infective drugs, with a focus on addressing unmet medical needs in infectious diseases. Microbiotix has received numerous federal contract and grant awards from agencies such as the National Institutes of Health (NIH) and the Department of Defense to advance its pipeline of therapeutic candidates, including treatments for viral and bacterial infections. This contract, awarded on August 2, 2006, has an ultimate completion date of February 1, 2009. Microbiotix's expertise lies in advancing novel anti-infective compounds through preclinical stages and into clinical development, and this contract demonstrates the company's capability to secure and execute large-scale federal research contracts.
Quick answers
Who was awarded contract HDTRA106C0042?
HDTRA106C0042 was awarded to Microbiotix, Inc. by Defense Contract Management Agency (Department of Defense) on August 2, 2006.
How much is contract HDTRA106C0042 worth?
The government has obligated $5,050,492 on HDTRA106C0042. Its current value, with exercised options, is $5,057,524.
Which agency awarded contract HDTRA106C0042?
Defense Contract Management Agency (Department of Defense) awarded HDTRA106C0042, with funding from Defense Threat Reduction Agency (Department of Defense).
Was contract HDTRA106C0042 competed?
The extent of competition for HDTRA106C0042 was full and open competition. The government received 113 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award